CryoCell International Inc 

$6.19
16
+$0.04+0.65% Thursday 19:59

통계

낮 최고
6.19
낮음
5.83
52W 높음
9.5
52W 낮음
3.67
거래량
3,701
평균 거래량
4,734
시가 총액
49.98M
주가수익률
-
배당수익률
-
배당금
-

예정

배당금

0%배당수익률
10년 성장률
해당 없음
5년 성장률
해당 없음
3년 성장률
해당 없음
1년 성장률
해당 없음

수익

15Oct예상
Q4 2022
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-1.35
-0.82
-0.3
0.23
예상 EPS
0.03
실제 EPS
0.13

다른 인물도 팔로우하고 있습니다

이 목록은 Stock Events에서 CCEL을(를) 팔로우하는 사람들의 워치리스트에 기반한 것입니다. 이는 투자 권유가 아닙니다.

경쟁자

이 목록은 최근 시장 이벤트에 기반한 분석입니다. 투자 권장사항이 아닙니다.

개요

Services to the Health Industry
Health Services
Health Technology
Medical Specialties
Manufacturing
Dental Laboratories
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Show more...
CEO
직원
82
국가
US
ISIN
US2288951088

목록